LIPELLA PHARMACEUTICAL
0.4147
08-October-24 10:26:38
15 minutes delayed
Stocks
+0.0107
+2.65%
Today's range
0.4020 - 0.4149
ISIN
N/A
Source
NASDAQ
-
24 Sep 2024 08:00:00 By Nasdaq GlobeNewswire
-
27 Aug 2024 08:00:00 By Nasdaq GlobeNewswire
-
Lipella Pharmaceuticals Launches Innovative Registry to Advance Oral Lichen Planus Research
22 Aug 2024 05:00:00 By Nasdaq GlobeNewswire
-
Lipella Pharmaceuticals Unveils Advanced Bladder Imaging Technique at ICICJ Conference
21 Aug 2024 05:00:00 By Nasdaq GlobeNewswire
-
Lipella Pharmaceuticals Doses First Two Patients in Phase 2a Oral Lichen Planus Clinical Trial
12 Aug 2024 05:00:00 By Nasdaq GlobeNewswire
-
01 Aug 2024 16:05:00 By Nasdaq GlobeNewswire
-
01 Aug 2024 08:00:00 By Nasdaq GlobeNewswire
-
29 Jul 2024 05:00:00 By Nasdaq GlobeNewswire
-
31 May 2024 08:00:00 By Nasdaq GlobeNewswire
-
29 May 2024 08:00:00 By Nasdaq GlobeNewswire
-
21 May 2024 08:00:00 By Nasdaq GlobeNewswire
-
Lipella Pharmaceuticals Expands its Advisory Board to Include Oncology Expertise
17 Apr 2024 08:00:00 By Nasdaq GlobeNewswire
-
05 Apr 2024 08:00:00 By Nasdaq GlobeNewswire
-
Lipella Pharmaceuticals Announces FDA Type C Meeting for LP-10 for Hemorrhagic Cystitis
03 Apr 2024 08:00:00 By Nasdaq GlobeNewswire
-
05 Mar 2024 08:00:00 By Nasdaq GlobeNewswire
-
Lipella Pharmaceuticals to Present at PropThink Digital Investor Conference
20 Feb 2024 08:00:48 By Nasdaq GlobeNewswire
-
20 Dec 2023 08:00:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >